OBJECTIVE: To quantify the relation between weight change and change in blood pressure, lipids and insulin levels, and determine if this relation differs by race or initial level of obesity. DESIGN: Longitudinal cohort study. SETTING AND PARTICIPANTS: Community-based sample of 3325 black and white men and women aged 18-30 y from four centers followed for 10 y. Women pregnant at baseline or 10th year exam and persons without a recorded weight at both exams were excluded. Participants whose baseline BMI was X25 kg/m 2 were classified as overweight. Height, weight, HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), fasting triglycerides, fasting insulin, and blood pressure were measured at baseline and Year 10. RESULTS: The mean (s.d.) of weight gained over 10 y was 10.5 (10.0) kg (black men), 11.7 (11.0) (black women), 7.7 (8.0) (white men), and 7.2 (10.0) (white women). An increase in weight was associated with adverse changes in all factors in all racesex groups. For example, a 9.1 kg (20-lb) weight increase in persons not overweight at baseline predicted an increase in LDL-C ranging from 0.23 mmol/l in black women to 0.28 mmol/l in black men and a decrease in HDL-C from 0.09 mmol/l (white women) to 0.11 mmol/l (white men) (all Po0.0001). The estimated change in triglycerides was greater in white than in black participants (Po0.02); no other racial differences were found. Changes in triglycerides (Po0.00001) and fasting insulin (P ¼ 0.004) were greater in men than in women. Only for LDL-C was a weight change-associated increase significantly different (greater, Po0.001) for nonoverweight persons than for those overweight at baseline. None of these associations were highly specific. Mean levels of LDL-C, HDL-C, and systolic blood pressure improved among all those who lost or did not gain weight. CONCLUSIONS: A 10 y weight gain in young adults of both races and sexes tends to confer adverse changes in their levels of LDL-C, HDL-C, triglycerides, fasting insulin, and blood pressure. This effect occurs regardless of initial weight, age, race, or gender.
Introduction
Obesity is associated with lower high-density lipoprotein (HDL)-cholesterol (HDL-C) levels, and elevated levels of LDLcholesterol (LDL-C) and blood pressure, but relations between weight change and change in these risk factors have not been precisely quantified, particularly in young adults. Of additional interest is that comparisons of the relation between obesity and risk factors, disease, or mortality have sometimes been found to be weaker in black than in white participants [1] [2] [3] [4] [5] [6] and in women than in men. 7 Initial level of fatness may influence the impact of weight change on these risk factors. If so, racial and ethnic differences in levels of obesity in the US population might thus influence the impact of weight change in different racial or ethnic groups. The Coronary Artery Risk Development in Young Adults (CARDIA) Study has followed a cohort of over 5000 black and white men and women aged 18-30 y for 10 y, recording serial measurements of weight and other risk factors. Here we consider three main questions: (1) What is the relation between weight change and change in HDL-C and LDL-C, triglycerides, systolic and diastolic blood pressure, and fasting insulin? (2) Are there significant race and sex differences in these relations? (3) Do these relations depend on initial level of obesity?
Study population
The baseline CARDIA examination took place in [1985] [1986] and included 5115 women and men from four centers in Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California. Participants were sampled from the total community or from selected census tracts, except in Oakland where a health plan membership was used. Sampling was designed to achieve balanced representation in each center among white and black, men and women, two age groups (18-24 y and 25-30 y), and two levels of education (high school or less and more than high school). In all 51% of eligible individuals participated of which 52% of participants were black individuals, and 55% were women. Details of the baseline study design have been published previously. 8 Subsequent to the baseline examination in 1985-1986, the cohort has been re-examined four times, most recently in 1995-1996 (Year 10). Retention of the surviving cohort at Year 10 was 78.5%. Among 3948 participants who attended the Year 10 examination, 605 women were eliminated because of pregnancy at either examination, 18 were eliminated for unrecorded weight, 354 were additionally eliminated from analyses of LDL-C, triglycerides and insulin analyses for fasting less than 9 h, 131 were eliminated from blood pressure analysis because they were taking antihypertensive medication, and 28 were eliminated from analyses of fasting insulin because they were taking insulin.
Risk factor measurements
Weight and height were measured in light clothing and without shoes. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m 2 ). Blood samples were drawn in the morning after an overnight fast using a Vacutainer containing EDTA. The cells were separated from plasma, and the plasma was transferred into airtight vials and stored at À701C until shipment on dry ice to the Northwest Lipid Research Laboratories, University of Washington, Seattle. Total cholesterol and triglycerides were measured enzymatically within 6 weeks of collection.
9 HDL-C was determined by precipitation with dextran sulfate/ magnesium chloride. 10 LDL-C was calculated using the Friedewald equation. 11 Insulin was measured by radioimmunoassay. 12 Blood pressure was measured in the right arm with a Hawksley random zero sphygmomanometer (W.A. Baum Company, Copaige, NY, USA) with the participant seated, after a 5-min rest. Three measurements were taken, and the averages of the latter two were used in analyses.
Smoking was defined by self-report as current, exsmoker, and never smoker at baseline and at the 10th year examination. Overweight was defined as BMI X25 kg/m 2 at baseline for men and women. 13 Self-reported levels of physical activity and alcohol consumption were not included in this analysis since preliminary analyses showed they had no important effect on the estimated rates of weight change-associated rates of change in risk factors.
Statistical analysis
All calculations were performed using PC -based SAS, version 6.12.
14 Distributions of baseline levels of weight, BMI, and other coronary heart disease (CHD) risk factors, and 10-y change in weight and BMI were examined and compared across categories of race, sex, and overweight status. The 10-y changes were calculated by subtracting baseline values from Year 10 values. Weight change in all analyses was expressed in 20 lb units (9.1 kg), a rounded value close to the overall mean gain in weight of 20.5 lb. The logarithms of triglycerides and fasting insulin values were used to produce dependent variables with more nearly normal distributions in the regression analyses. All indicated P-values are twosided.
Multivariate linear regression models were constructed separately for persons in nonoverweight and overweight categories in each race-sex group. The changes in each of the six risk factors (LDL-C, HDL-C, log triglycerides, log fasting insulin, systolic, and diastolic blood pressure) were the dependent variables, and weight change (in 9.1 kg or 20 lb units), 10-y average weight, age and education at baseline, and cigarette smoking (as two dichotomous variables for former and current smoking status at the 10th year examination) were the independent variables. Maximum likelihood estimates of the coefficients of weight change for each of the six dependent variables were calculated using a multivariate linear regression model in which each element of the response vector is modeled as a linear function of the six independent variables. This method acknowledges the correlations between the dependent variables, provides simultaneous estimates of all six coefficients of weight change, and so avoids the use of six univariate multiple linear regression analyses for each race-sex-weight category. Details of the theory are given in Anderson's text. 15 T-tests were used to test that estimated coefficients of weight change differ significantly from zero. Race, sex, and normal weight/overweight comparisons of each of the six coefficients of weight change were based on the sum of their squared differences, which are distributed as w 2 with appropriate degrees of freedom when the true differences are zero. A smoking-weight change interaction term was initally included in the regression model for each race-sex group, motivated by findings that cigarette smoking modifies levels of triglycerides 16 , LDL, and HDL. 17 This term was omitted in the final models, however, since it was found not to be significant.
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In addition to the use of multivariate linear regression, we used a second approach to quantify the relation between weight change and change in CHD risk factors. We prepared two by two tables, for all race-sex groups, of the numbers of persons showing decreases (or no change) and increases in each factor among nonweight gainers, and among weight gainers. From these we calculated the ratios and their 95% confidence intervals of the odds that a weight gainer would experience an adverse change in a risk factor relative to the odds that a nongainer would experience an adverse change in that risk factor. 18 This ratio is identical to the ratio of odds that a nongainer would experience a favorable change in a risk factor to the odds that a person who gained weight would experience a favorable change.
Results

Baseline characteristics
White participants tended to be slightly older than black participants (Table 1 ). Black and white men had similar weights and body mass indices at baseline, but overweight black women were 3.4 kg heavier on average than overweight white women. The baseline prevalence of overweight was nearly the same in black and white men, and twice as high in black women as in white women. Education levels were higher in white participants. Nonoverweight black men smoked more than nonoverweight white men; white women smoked more than black women. White men had higher levels of LDL-C and triglycerides, and lower HDL-C levels than black men; however, black men had higher levels of systolic blood pressure and fasting insulin. Except for triglycerides, black women had more adverse risk factor profiles than white women.
Ten year changes in risk factor profiles
With the exception of LDL-C, the percentages of persons with clinically elevated risk factor values appreciably increased during the 10-y interval. Obesity (BMI 430) increased from 11 to 27%, HDL-C values below 1.03 mmol/ l from 14 to 27%, triglycerides above 2.26 mmol/l from 2 to 6%, fasting insulins above 25 pmol/l from 4 to 6%, and hypertension (SBP4140 mmHg and/or DBP 490 mmHg) from 2 to 7%. These numbers vary by race and sex, but the ratios of 10-y percentages to baseline percentages across race and sex are fairly constant. Thus, obesity level increased from 7 to 18% in white participants and 16 to 37% in black participants.
Weight change by race and sex A modified Box plot ( Figure 1 ) shows the distribution of 10 y weight changes by race and sex. 
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The mean weight increase over 10 years among black women was 11.8 kg, compared to 7.2 kg among white women (Po0.0001). The mean weight gain among black men was 10.5 kg compared to 7.7 kg among white men (Po0.0001). These values were calculated from all members of each group, including those who lost weight. Weight change was skewed to the right in all groups; the 90th percentile ranged from 25.4 kg, in black women, to 17.0 kg, in white women. In all, 16% of white participants and 12% of black participants either lost or did not gain weight. Table 2 shows the estimated changes in LDL-C, HDL-C, triglycerides, fasting insulin, and blood pressure for a 20 pound weight gain in men and in women adjusted for age and education at the first examination, average weight at the first and 10th year examination, previous and current smoking status at the 10th year examination, and race. Since logarithms of triglycerides and fasting insulin were used in the linear regression model, their associated values in the table represent the estimated mean ratios of each of these quantities after 10 y to their baseline values for a 20 pound increase in weight. Thus, for example, nonoverweight white men had an estimated 16% increase in triglycerides level for a 9.1 kg weight increase. All estimated changes are significantly different from zero (Po0.000001). The impact of weight change is significantly greater in men than in women for LDL-C (P ¼ 0.018), triglycerides (Po0.00001), and fasting insulin (P ¼ 0.004).
Impact of weight change on risk factors
The sex-and race-specific estimates of risk factor changes per 9.1 kg weight gain, adjusted (except for race) as in Table 2 , are shown by baseline overweight status in Table 3 . LDL-C and diastolic blood pressure changes are less for those overweight as compared to those not overweight at baseline in all race/sex groups, although only significantly so for LDL-C (Po0.00001). The larger values of triglycerides changes for white participants were the only significant racial difference (Po0.02). With the exception of systolic and diastolic blood pressure, the changes in all factors in all groups were significant (Po0.0001). Apart from a tendency for overweight values to be smaller for these two factors, no clear pattern emerged. Estimates ranged from 0.0 to 3.6 mmHg for systolic and 0.6 to 2.7 mmHg for diastolic blood pressure. Systolic blood pressure changes for overweight white and black males and overweight black females, and diastolic values for all black females were significant at Po0.005. A comparison of the estimated changes in all six risk factors calculated separately for each of the four geographic centers revealed no significant differences (data not shown). Impact of weight change on Cardiovascular Disease Risk JE Norman et al
Nonweight gainers
Those people who either lost or did not gain weight during the 10-y interval, while a minority, nevertheless provide information concerning the relation between weight change and change in those risk factors considered here. The percentages of black men and women, and white men and women in this category were 12, 10, 13, and 20, respectively, with mean weight losses of 4.1, 5.9, 2.9, and 3.6 kg, respectively (Table 4 ). All four groups (without regard to baseline overweight status) experienced decreases in mean levels of LDL-C and systolic blood pressure, and a mean increase in HDL-C. Although several black-white participants differences in risk factor changes are suggestively large, none reached significance at the level of P ¼ 0.008 (the Bonferroni adjusted value for six comparisons for an overall Type I error of 0.05). The prevalence of cigarette smoking at year 10 in this group was significantly greater than that in those who gained weight (35 vs 26%, Po0.00001). Neither the proportions of persons reporting injury or serious illness nor those embarking on weight reducing diets differed for those who gained weight and those who did not (data not shown).
Relative risks for adverse changes in risk factors
Weight change in our data is only modestly predictive of changes in CHD risk factors as indicated by the sizes of the regression model R 2 values, a little more than 9% in men and in women. The limited predictive value of weight change for adverse 10-y changes in the risk factors prompted us to make a second analysis. We calculated odds ratios from two by two tables that show the numbers of weight gainers and nonweight gainers who did and did not experience adverse risk factor changes after 10 y. Table 5 displays the odds ratios for an adverse change in each risk factor among two categories of weight gainers (10% or less and more than ten percent) relative to the nonweight gainers, for each racesex group. For example, the first row of the table shows that the odds for an increase in LDL-C in black males who gained no more than 10% of their baseline weight is 1.8 times the With the exception of LDL-C, none of the overweight/non-overweight differences were significant. Only the racial difference in triglycerides values was significant (Po0.02). f Table entries for triglycerides and fasting insulin represent ratios associated with a 9.1 kg weight gain; eg, a 9.1 kg weight gain in nonoverweight white men produces an average increase in triglycerides of 37%.
Impact of weight change on Cardiovascular Disease Risk JE Norman et al odds of an LDL-C increase in black males who lost or did not gain weight. With the exceptions of diastolic blood pressure in black men and systolic blood pressure in white men, odds ratios for an adverse change in all six risk factors in anyone with a 10-y weight gain of more than 10% were significantly greater than one.
Discussion
We have documented strong relations between mean weight gain over 10 y and adverse changes in mean values of lipids and fasting insulin in young adult black and white men and women, regardless of overweight status at baseline. Statistically, but perhaps not clinically, significant increases in systolic and diastolic blood pressures were also found. A distinction between these terms is problematic, but it is clear that with sufficiently large cohorts, an arbitrarily small difference can be statistically significant, even though a change of that magnitude in an individual would not be considered clinically significant. The numbers of men and women of both races in our analyses were sufficient to provide 90% power to detect gender or racial differences of about 0.05 mmol/l for LDL-C, 0.04 mmol/l for HDL-C, a 7% change in triglycerides, an 8% change in fasting insulin, and changes in both systolic and diastolic blood pressures of about 1.5 mmHg. Any of these differences for a sizeable cohort such as ours may well prove to be harbingers for increased cardiovascular disease risk 10-20 y in the future. We found significant gender differences in the degree of weight-associated change for LDL-C, triglycerides and fasting insulin, and a significant racial difference for triglycerides. Our data also indicate that overweight black men and women, and white men have smaller rates of increase in LDL-C and triglycerides than do their nonoverweight counterparts, perhaps because much of the rise in these values for overweight people had already occurred.
There are few other data comparing relations of body fatness to risk factor levels between blacks and whites, particularly longitudinally. The National Growth and Health Study (NGHS), a longitudinal study of obesity and cardiovascular risk in black and white girls from age 9 to 14 y, found that black girls had significantly smaller blood pressure increases for a unit change in BMI compared to white girls over a 4-5 y period. 19 The Princeton School Study Impact of weight change on Cardiovascular Disease Risk JE Norman et al used reported weight at age 18 and current measurements of LDL-C, HDL-C, triglycerides, and systolic and diastolic blood pressures among random-recall and hyperlipidemic groups of 30-55 y-old white and black men and women. They found that weight gain in white individuals between age 18 and ages 30-55 y was inversely associated with HDL-C level, and positively associated with triglycerides, systolic and diastolic blood pressure measured at the older age. Similar, but less consistent and significant, trends were found in blacks over the 12-37 y time interval. This study also reported that the random-recall group of white men in the lowest quartile of weight at age 18 all had current values of total cholesterol, triglycerides, and systolic and diastolic blood pressures that were lower than those observed in white men who had been in the upper quartile of weight at age 18 20 . The Pitt County Study found that weight gain over a 5-y period among nonoverweight black men and women at baseline significantly predicted a blood pressure increase. In contrast with our findings, no significant 5-y increases in systolic or diastolic pressures were found among black men and women classified as overweight (baseline BMIs of at least 27.8 and 27.3, respectively). 21 Three cross-sectional analyses have found weaker relations between weight or obesity and risk factors in black participants than in white participants. In the Bogalusa Heart Study, cross-sectional correlations between weight/ height 3 and HDL-C were much stronger in white men aged 17-26 y than in white women or black individuals. 5 In the Charleston Heart Study, cross-sectional correlations between BMI and systolic blood pressure were significant in white but not black men. 3 Baseline cross-sectional relations between skinfold thickness and triglycerides in the CARDIA and ARIC cohorts were significantly weaker in black individuals than white individuals. 6 The relation between mortality and obesity for both black individuals and white individuals has been reported in at least three cohorts. In both the Women's Pooling Project and an American Cancer Society cohort, weaker or no relation was found between BMI and mortality in black women compared to white women. 1,2 BMI was found to be predictive of all-cause and CHD mortality in white, but not in black men in the Charleston Heart Study, 3 while BMI predicted all-cause mortality in white men and not in black men in the Evans County Study. 4 In contrast with these results, the findings of our study suggest no clear pattern of differential CHD risk for black and white participants attributable to weight change. Our data also indicate that for LDL-C, triglycerides, and fasting insulin weight gain had a statistically stronger effect in men than in women. This agrees with findings from the Framingham Study, where relations between weight change and changes in serum cholesterol, systolic blood pressure, blood glucose, and uric acid were all weaker in women than in men. 7 The strengths of this study are its population-based design, long follow-up, availability of actual standardized, rather than reported, CHD risk factor measures, a high degree of quality control for measures collected across time, and adequate numbers of men and women of both races for strong comparisons of race and gender. A major limitation is the lack of reliable (not self-reported) data on physical activity levels in the CARDIA participants since we know that it affects both blood pressure, lipid, and insulin levels. Also, our reliance on BMI values at the beginning of the 10 y period dichotomizes individuals into nonoverweight/overweight categories even though nearly half of all black individuals and one-third of all white individuals not overweight at baseline had become so by Year 10. Thus, our analysis of the effect, by overweight status, of weight gain on risk factors has ignored any potential effect that the rate of weight gain may have had on these factors. Lastly, the predictive value of weight gain for associated adverse changes in risk factors in our data is rather limited; of all persons studied who gained weight, 32% had an increase in HDL-C, 52% had a decrease in LDL-C, 40% had a decrease in triglycerides, 53% had a decrease in systolic blood pressure, 35% had a decrease in diastolic pressure, and 32% had a decrease in fasting insulin. In addition to obesity, important, but as yet unidentified, factors are operating to effect adverse changes in the conventional indicators of cardiovascular disease risk that we have considered here.
In summary, we have found no large differences between black and white individuals for the effect of weight change on the six risk factors studied. Weight gain during early adulthood tends to bring adverse changes in blood lipids, fasting insulin, and blood pressure in all race-sex groups and this effect is independent of initial weight and age. Our findings have important, but not unanticipated, implications for preventive medicine.
